T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS

BACKGROUND AND OBJECTIVES: Rituximab is used with variable success in difficult FSGS. Because B cell depletion significantly affects T cell function, we characterized T cell subsets in patients with FSGS to determine if an immunologic signature predictive of favorable response to rituximab could be...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin J Am Soc Nephrol
Principais autores: Chan, Chang-Yien, Liu, Isaac Desheng, Resontoc, Lourdes Paula, Ng, Kar-Hui, Chan, Yiong-Huak, Lau, Perry Yew-Weng, Than, Mya, Jordan, Stanley C., Lam, Kong-Peng, Yeo, Wee-Song, Yap, Hui-Kim
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4974889/
https://ncbi.nlm.nih.gov/pubmed/27269610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.11941115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados